Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EWY vs GSK✓SelectedUSD · GSKEWY vs GSK performance historyLatest closeAs of-4.36%11/16
Stock and ETF performance explorer

EWY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+92.7%
GSK return
+47.4%
Excess return
+45.3%
Maximum drawdown
-40.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.4%-0.1%-4.3%-4.4%
7D-3.9%-1.3%-2.6%-3.8%
30D-9.2%+2.7%-12.0%-9.6%
3M-24.0%+2.7%-26.7%-24.4%
6M-23.7%+3.3%-27.0%-24.6%
YTD+40.5%+6.5%+34.0%+38.1%
1Y+48.3%+10.7%+37.7%+44.8%
3Y+133.7%+64.4%+69.3%+106.4%
All+92.7%+47.4%+45.3%+62.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling